The study found that elevated levels of C-X-C chemokine receptor type 2 (CXCR2), IL-1 receptor antagonists, and IL-2 receptor antagonists were associated with the onset and progression of pneumonitis, suggesting a potential link between these immune markers and treatment-induced lung inflammation [70]. This evidence concerns the gene CXCR2 and pneumonitis.